Heberprot-P: use in diabetic foot

Here is described the treatment of a Venezuela female patient, who was diagnosed whith an ischemic diabetic foot, caused by a lasion on the top of the left foot. The metabolic parameters were stabilized after treatment. The infection of the lesion was controlled, and the wound was debrided, and furt...

Full description

Bibliographic Details
Main Authors: Cecilio González, Julio Baldomero, Liubka María Pérez, Nancy Paredes, Aída R Hernández, Exavier Campos, Felipe Piñol
Format: Article
Language:English
Published: Elfos Scientiae
Series:Biotecnología Aplicada
Subjects:
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&lng=en&tlng=en
_version_ 1819051302889455616
author Cecilio González
Julio Baldomero
Liubka María Pérez
Nancy Paredes
Aída R Hernández
Exavier Campos
Felipe Piñol
author_facet Cecilio González
Julio Baldomero
Liubka María Pérez
Nancy Paredes
Aída R Hernández
Exavier Campos
Felipe Piñol
author_sort Cecilio González
collection DOAJ
description Here is described the treatment of a Venezuela female patient, who was diagnosed whith an ischemic diabetic foot, caused by a lasion on the top of the left foot. The metabolic parameters were stabilized after treatment. The infection of the lesion was controlled, and the wound was debrided, and further treated with 75 µg Heberprot-P until complete closure for 92 days, with 29 doses of the product.
first_indexed 2024-12-21T12:01:47Z
format Article
id doaj.art-48f712267c904dd09cc01aa87b88e272
institution Directory Open Access Journal
issn 1027-2852
language English
last_indexed 2024-12-21T12:01:47Z
publisher Elfos Scientiae
record_format Article
series Biotecnología Aplicada
spelling doaj.art-48f712267c904dd09cc01aa87b88e2722022-12-21T19:04:49ZengElfos ScientiaeBiotecnología Aplicada1027-2852272177178S1027-28522010000200014Heberprot-P: use in diabetic footCecilio González0Julio Baldomero1Liubka María Pérez2Nancy Paredes3Aída R Hernández4Exavier Campos5Felipe Piñol6Hospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHere is described the treatment of a Venezuela female patient, who was diagnosed whith an ischemic diabetic foot, caused by a lasion on the top of the left foot. The metabolic parameters were stabilized after treatment. The infection of the lesion was controlled, and the wound was debrided, and further treated with 75 µg Heberprot-P until complete closure for 92 days, with 29 doses of the product.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&lng=en&tlng=enpie diabéticoheberprot-p
spellingShingle Cecilio González
Julio Baldomero
Liubka María Pérez
Nancy Paredes
Aída R Hernández
Exavier Campos
Felipe Piñol
Heberprot-P: use in diabetic foot
Biotecnología Aplicada
pie diabético
heberprot-p
title Heberprot-P: use in diabetic foot
title_full Heberprot-P: use in diabetic foot
title_fullStr Heberprot-P: use in diabetic foot
title_full_unstemmed Heberprot-P: use in diabetic foot
title_short Heberprot-P: use in diabetic foot
title_sort heberprot p use in diabetic foot
topic pie diabético
heberprot-p
url http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&lng=en&tlng=en
work_keys_str_mv AT ceciliogonzalez heberprotpuseindiabeticfoot
AT juliobaldomero heberprotpuseindiabeticfoot
AT liubkamariaperez heberprotpuseindiabeticfoot
AT nancyparedes heberprotpuseindiabeticfoot
AT aidarhernandez heberprotpuseindiabeticfoot
AT exaviercampos heberprotpuseindiabeticfoot
AT felipepinol heberprotpuseindiabeticfoot